Search
for
Sort by
Research 61–90 of 1000+
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- The risk of dementia with the use of 5 alpha reductase inhibitors
- An Old Problem with a New Cause-5 Alpha Reductase Inhibitors and Persistent Sexual Dysfunction
- STEROID HORMONES IN GERIATRICS
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- Saw Palmetto
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- Menopause
- Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice